Article
Allogeneic hematopoietic stem cell transplantation could improve survival of cytogenetically normal adult acute myeloid leukemia patients with DNMT3A mutations.
American journal of hematology - 1 Nov 2015
Xu Yang, Sun Yanjun, Shen Hongjie, Ding Lin, Yang Zhen, Qiu Huiying, Sun Aining, Chen Suning, Wu Depei
Abstract excerpt
DNMT3A mutations are frequent in cytogenetically normal acute myeloid leukemia (cn-AML) patients and associated with poor survival. The role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in DNMT3A(mut) cn-AML patients remains unclear. In this study, we retrospectively analyzed the prognostic impact of DNMT3A mutations and explored the role of allo-HSCT in 308 cn-AML patients who received...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
